StockData
Verrica Pharmaceuticals Inc. logo

Verrica Pharmaceuticals Inc. (VRCA) income statement

VRCANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$2.74−0.14 (-5.03%)

Close on Nov 20, 2026Market cap $47.07MP/E –Yield –

Verrica Pharmaceuticals Inc. financial ratios

See a number that looks wrong?